Table 3.
Significance for each parameter studied between grouped SS, VMAT, and HT (significance identified when ).
p‐value | |||||||
---|---|---|---|---|---|---|---|
SS& VMAT | SS & HT | VMAT & HT | |||||
PTV |
|
0.957 |
|
|
|||
Mean dose (Gy) | 0.213 |
|
|
||||
(%) | 0.978 | 0.168 | 0.152 | ||||
|
0.058 | 0.015 |
|
||||
|
0.117 | 0.055 |
|
||||
|
0.176 | 0.083 | 0.003 | ||||
Cord |
|
0.017 | 0.507 | 0.323 | |||
Bronchus |
|
0.611 | 0.218 | 0.742 | |||
Esophagus |
|
0.686 | 0.993 | 0.755 | |||
Heart |
|
0.152 | 0.552 | 0.552 | |||
Trachea |
|
0.626 | 0.004 | 0.020 | |||
Total lung | MLD (Gy) | 0.561 | 0.005 | 0.001 | |||
(cm3) | 0.779 | 0.369 | 0.113 | ||||
(%) | 0.756 | 0.341 | 0.093 | ||||
(%) | 0.918 | 0.247 | 0.119 | ||||
(%) | 0.990 | 0.002 | 0.002 | ||||
(%) | 0.898 |
|
|
||||
Cont. lung | (%) | 0.778 | 0.091 | 0.044 | |||
(%) | 0.204 |
|
|
||||
Efficiency | MLC Motion | 0.123 | N/A | N/A | |||
Monitor Units | 0.607 | 0.516 | 0.787 | ||||
Delivery time (min) |
|
|
|